See more Today's research, tomorrow's health Vall d'Hebron Research Institute We work to identify and apply new solutions to society’s health problems, achieving leadership and excellence in clinical and translational biomedical research at the national and international levels. See more Today's research, tomorrow's health The Paediatric Research Hub was established It will make it possible to promote research in pediatrics and adolescence, making the center's experience visible and pooling efforts and capabilities to carry out initiatives with a global vision. See more Today's research, tomorrow's health More than 70 research groups These research groups are structured in 7 collaborative research spaces (eCORE) with the aim of solving some of the main challenges in the field of health. We promote impact research, aimed at improving the well-being of society. See more Today's research, tomorrow's health Leaders in clinical trials Clinical trials are our best strategy for making new therapeutic approaches and new treatment opportunities available to patients. The Vall d'Hebron Campus is an international benchmark in clinical trials. We closed the year 2022 with a record figure of 1,761 active clinical trials. See more Today's research, tomorrow's health VHIR daily news All the latest news and information on major advances in research, institutional milestones, teaching and management. Find out what's happening at the Vall d'Hebron Research Institute! Previous Next Get to know our collaborative research spaces (eCORE) Global Health Chronic, Prevalent Diseases & Aging Woman & Child Health & Rare Diseases Brain & Mind and Behaviour Cancer Personalised Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation NEWS Latest news The NanoDIRE-CT project progresses toward targeted tumor stem cell therapy with nanobodies During the last year, the collaboration between Vall d’Hebron and ZeClinics has found three nanobody candidates with potent anticancer properties in zebrafish model. Positive preliminary results of the study of HIPRA's vaccine against COVID-19 This clinical trial is part of the European project RBDCOV, led by HIPRA in which Vall d'Hebron participates, whose recruitment is still open. Vall d'Hebron organizes the meeting of the European research group on pediatric sarcomas The meeting has been the meeting point of the EpSSG group dedicated to research to improve the treatment of childhood and adolescent soft tissue sarcomas. See more All the tools to research at your disposal The Core Facilities offer state-of-the-art solutions for all the needs that arise during the biomedical research process. Each unit is led by a person in charge of the day-to-day management of the activities, the evaluation of the quality of the service and the treatment to the clients. See more COLLABORATE Help us to make research move forward Our research activity seeks to discover less invasive therapies, to find treatments for incurable diseases and to anticipate diagnoses. Discover how you can collaborate. Help us to make research move forward. Because today’s research is tomorrow’s health. Donate We have the best professionals Jorge Nestor Garcia Perez Predoctoral researcher Infectious Diseases Read more Cristina Solé Marce Main researcher Rheumatology Read more Manuel Hernández González Main researcher Translational Immunology Read more Esperanza Zuriguel Pérez Head of group Multidisciplinary Nursing Research Group Read more See more
